Canada - TSX Venture Exchange - TSX-V:PTEC - CA74260Q1028 - Common Stock
The current stock price of PTEC.CA is 0.57 CAD. In the past month the price increased by 14%. In the past year, price increased by 280%.
ChartMill assigns a technical rating of 10 / 10 to PTEC.CA. When comparing the yearly performance of all stocks, PTEC.CA is one of the better performing stocks in the market, outperforming 94.56% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to PTEC.CA. PTEC.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months PTEC.CA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS decreased by -89.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -273.92% | ||
| ROE | -4727.01% | ||
| Debt/Equity | 0.19 |
Principal Technologies, Inc. engages in the operations in healthcare technology including the project management of international scale clinical studies primarily related to medical device technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-01. The firm is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The firm operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
PRINCIPAL TECHNOLOGIES INC
2500 - 700 West Georgia Street
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16046096112
Principal Technologies, Inc. engages in the operations in healthcare technology including the project management of international scale clinical studies primarily related to medical device technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-11-01. The firm is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The firm operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
The current stock price of PTEC.CA is 0.57 CAD. The price increased by 3.64% in the last trading session.
PTEC.CA does not pay a dividend.
PTEC.CA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
PRINCIPAL TECHNOLOGIES INC (PTEC.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).